Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novabay Pharmaceuticals (NY: NBY ) 0.6891 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novabay Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session April 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session April 21, 2023 Via Benzinga NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network April 21, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results March 30, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Earnings Preview: NovaBay Pharmaceuticals March 29, 2023 Via Benzinga Earnings Scheduled For March 30, 2023 March 30, 2023 Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. Via Benzinga NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023 March 23, 2023 From NovaBay Pharmaceuticals, Inc: Via Business Wire Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel March 14, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health March 07, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7 February 06, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 January 31, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market January 17, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session December 30, 2022 Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 14, 2022 We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday! Via InvestorPlace NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China November 29, 2022 From NovaBay® Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm November 17, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results November 14, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday November 17, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday November 16, 2022 On Wednesday, 70 companies set new 52-week lows. Via Benzinga NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split November 14, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14 November 09, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum October 26, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV October 19, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Tuesday October 25, 2022 On Tuesday, 120 companies set new 52-week lows. Via Benzinga NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season October 18, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket October 10, 2022 Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 10, 2022 We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them! Via InvestorPlace NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale October 10, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price October 07, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.